Federal contractors / ASTRIX TECHNOLOGY LLC

Federal contract award

75N91021F00070

SUPPORT SERVICES, RESEARCH ANALYST 13 FOR THE LABORATORY OF GENOME INTEGRITY, CCR

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNIH NCI
NAICS541712
PSCR431 — SUPPORT- PROFESSIONAL: HUMAN RESOURCES
Parent award / vehicleHHSN261201700002B
Set-asideNot reported
Pricing typeLABOR HOURS
Obligations$308.2K
Current contract value$308.2K
Potential contract value / ceiling$315.2K
Start dateSep 4, 2021
Current end dateSep 3, 2024
Potential end dateSep 3, 2024
Latest award activityJul 23, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 23, 2026P00004$-7.0KTO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.
Jul 9, 2024P00003$2.9KOPTION PERIOD 2: SCIENTIFIC SUPPORT SERVICES (SSS) RESEARCH ANALYST 13 FOR THE LABORATORY OF GENOME INTEGRITY, CENTER FOR CANCER RESEARCH, NATIONAL CANCER INSTITUTE.
Aug 22, 2023P00002$104.5KOPTION PERIOD 2: SCIENTIFIC SUPPORT SERVICES (SSS) RESEARCH ANALYST 13 FOR THE LABORATORY OF GENOME INTEGRITY, CENTER FOR CANCER RESEARCH, NATIONAL CANCER INSTITUTE.
Aug 23, 2022P00001$102.0KOPTION PERIOD 1: SCIENTIFIC SUPPORT SERVICES (SSS) RESEARCH ANALYST 13 FOR THE LABORATORY OF GENOME INTEGRITY, CENTER FOR CANCER RESEARCH, NATIONAL CANCER INSTITUTE. THE CONTRACTOR SHALL PROVIDE SUPPORT SERVICES TO SATISFY THE OVERALL OPERATIONAL OBJ
Sep 2, 20210$105.9KSUPPORT SERVICES, RESEARCH ANALYST 13 FOR THE LABORATORY OF GENOME INTEGRITY, CCR

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.